Lupin Limited announced that it has appointed Johnny Mikell as President and Global Head of Quality of the company. In his most recent engagement, Johnny was the global head of quality and compliance at Apotex. He has significant experience in global quality operations and compliance in the generics, branded and active pharmaceutical ingredient (API) segments, it added. Johnny will be based out of Lupin's US offices and will lead the company's Quality function globally; he will help steer the company towards enhanced standards of Quality and Compliance.